Chronic Lymphocytic Leukemia | Meet The Professors: Management of Chronic Lymphocytic Leukemia

published 2 months ago by Dr Neil Love

Featuring a roundtable discussion with Drs Ian W Flinn, John M Pagel and Tanya Siddiqi, including the following topics: Case: A woman in her late 60s with newly diagnosed chronic lymphocytic leukemia (CLL) who receives acalabrutinib — Gigi Chen, MD (0:00) Case: A woman in her mid-60s with CLL who responds to ibrutinib but has an elevated absolute lymphocyte count — Laurie Matt-Amaral, MD, MPH (7:40) Optimal choice and sequence of BTK inhibitors and Bcl-2 inhibitors in patients with CLL (11:58) Case: A man in his late 70s with relapsed CLL who receives venetoclax/rituximab — Ranju Gupta, MD (22:08) Case: A man in his mid-70s with relapsed CLL who is otherwise fit and receives first-line treatment with venetoclax/obinutuzumab — Dr Gupta (28:04) Case: A woman in her late 80s with CLL who develops congestive heart failure on ibrutinib — Dr Chen (34:11) Practical issues in the use of BTK inhibitors and Bcl-2 inhibitors for patients with CLL (38:40) CME information and select publications

more episodes from Research To Practice | Oncology Videos